It has been shown that SNHG2 can block the transcription of CCAAT/enhancer binding protein β (CEBPB)-mediated growth differentiation factor 15 (GDF15), further leading to the apoptosis of ovarian cancer cells.51 This evidence concerns the gene GDF15 and ovarian carcinoma.